 |
MiroBio
Last updated: October 12, 2024
Founders: Richard Cornall and Simon Davis
UK | Funding: $130M (+)
Website: http://www.mirobio.com/
MiroBio develops novel, best-in-class therapeutics that bring significant benefits to patients suffering from a range of auto-immune diseases. MiroBio's medicines will activate natural mechanisms to regain control of over-active immune responses triggering these diseases.
Website: http://www.mirobio.com/
MiroBio develops novel, best-in-class therapeutics that bring significant benefits to patients suffering from a range of auto-immune diseases. MiroBio's medicines will activate natural mechanisms to regain control of over-active immune responses triggering these diseases.
